Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus
It has been extensively reported that diabetes mellitus (DM) patients have a higher risk of developing Alzheimer's disease (AD), but a mechanistic connection between both pathologies has not been provided so far. Carbohydrate-derived advanced glycation endproducts (AGEs) have been implicated in...
Main Authors: | Tony Valente, Alejandro Gella, Xavier Fernàndez-Busquets, Mercedes Unzeta, Nuria Durany |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-01-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996109002496 |
Similar Items
-
CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
by: Vasileios Papaliagkas, et al.
Published: (2023-05-01) -
Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation
by: Marc D Tambini, et al.
Published: (2020-02-01) -
Possible Modification of Alzheimer Disease by Statins in Midlife: Interactions with Genetic and Non-Genetic Risk Factors
by: Mitsuru eShinohara, et al.
Published: (2014-04-01) -
2015: which new directions for Alzheimer’s disease?
by: Xénia eLATYPOVA, et al.
Published: (2014-12-01) -
AMBAR, an Encouraging Alzheimer's Trial That Raises Questions
by: David A. Loeffler
Published: (2020-05-01)